He goes to French justice to have the freedom to choose his vaccine

He goes to French justice to have the freedom to choose his vaccine
He goes to French justice to have the freedom to choose his vaccine

In Loiret, a man seized the administrative court to ask for the possibility of designating his vaccine against Covid-19. However, the authorities do not consider this freedom of choice to be fundamental.

In order to be vaccinated against Covid-19, a resident of Villemandeur, in Loiret, made an appointment via Doctolib. On the site he discovered that for the desired date, namely April 16, only slots with the AstraZeneca vaccine were available. Reluctant to the idea, he seized the administrative court, reports France Bleu.

In the request filed with the administrative court of Orleans, he asks that the freedom to choose his vaccine be recognized to everyone.

The first hearing was held on Wednesday April 7. According to the arguments put forward by a representative of the Loiret prefecture, vaccination is not compulsory but optional.

“Therefore, the freedom to choose your vaccine can not be considered a fundamental freedom”, it is argued.

An official from the Regional Health Agency, also present at the hearing, argued that each step of the vaccine strategy targets a certain age group, which may involve a particular vaccine. In addition, the distribution of doses also depends on stocks, volumes supplied and approval dates.

The court must decide in the coming days.

Four licensed vaccines

For the moment, four vaccines are authorized in the EU and in France therefore: that of Pfizer / BioNtech, from the end of 2020, followed by that of Moderna in early January 2021. Both are based on the same principle, messenger RNA. At the end of January, the AstraZeneca viral vector vaccine was given the green light for use in the EU. Finally, the Johnson & Johnson vaccine was authorized by the European regulator in March and is due to arrive in France from April 19.

While Pfizer / BioNtech and Moderna are authorized for people over 18 years old, AstraZeneca is now injected in France to patients over 55 years old. Similar restrictions are in place in several other EU countries, after reports of blood clots and deaths. On April 7, the European Medicines Agency (EMA) announced 18 deaths linked to the AstraZeneca vaccine in Europe and the United Kingdom. According to the regulator, clots should be listed as a “very rare” side effect. The EMA nevertheless believes that the risk / benefit balance remains positive.

As for France, according to the National Medicines Safety Agency (ANSM), as of March 25, four deaths were reported following thromboembolic disorders occurring after the injection of AstraZeneca.

Some French people therefore shun this drug: last weekend several vaccination centers in Pas-de-Calais and the North returned unused batches for lack of volunteers.

Get the latest news delivered to your inbox

Follow us on social media networks

PREV WTO: Global trade recovery promises to be strong but uneven
NEXT 107 million doses delivered to the EU in Q1 2021